PTC Therapeutics Inc (PTCT) Common Stock USD0.001
0.51%- This stock can be held in a
Stocks and Shares ISASell:$49.73
Buy:$49.90
Change:
$0.41
(0.83%)
$0.41
(0.83%)Prices delayed by at least 15 minutes
Sell:$49.73
Buy:$49.90
Change:$0.41
(0.83%)
$0.41
(0.83%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 January 2025 | Matthew B KleinCOO | Sell Tax related | 2,402 | $44.50 | $106,889.00 | 283,830 |
| 8 January 2025 | Mark Elliott BouldingChief Legal/Compliance Officer | Sell Tax related | 1,998 | $44.50 | $88,911.00 | 106,848 |
| 8 January 2025 | Neil Gregory AlmsteadCTO | Sell Tax related | 1,552 | $44.50 | $69,064.00 | 103,231 |
| 8 January 2025 | Eric PauwelsChief Level Officer | Sell Tax related | 2,136 | $44.50 | $95,052.00 | 86,805 |
| 8 January 2025 | Lee Scott GoldenChief Level Officer | Sell Tax related | 1,198 | $44.50 | $53,311.00 | 78,651 |
| 8 January 2025 | Christine Marie UtterChief Accounting Officer | Sell Tax related | 1,662 | $44.50 | $73,959.00 | 64,321 |
| 8 January 2025 | Neil Gregory AlmsteadCTO | Sell Tax related | 107 | $44.50 | $4,761.50 | 5,975 |
| 7 January 2025 | Matthew B KleinCOO | Sell Tax related | 2,142 | $45.34 | $97,118.28 | 286,232 |
| 7 January 2025 | Mark Elliott BouldingChief Legal/Compliance Officer | Sell Tax related | 1,543 | $45.34 | $69,959.62 | 108,846 |
| 7 January 2025 | Neil Gregory AlmsteadCTO | Sell Tax related | 1,265 | $45.34 | $57,355.10 | 104,783 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 December 2024 | Mark Elliott BouldingChief Legal/Compliance Officer | Sell Option/Award related | 83,640 | $52.26 | $4,371,026.40 | 92,389 |
| 2 December 2024 | Neil Gregory AlmsteadCTO | Sell Option/Award related | 58,345 | $51.97 | $3,032,189.65 | 94,813 |
| 22 May 2024 | Jerome B. ZeldisIndependent Director | Sell Option/Award related | 20,000 | $38.24 | $764,800.00 | 14,500 |
| 2 December 2024 | Christine Marie UtterChief Accounting Officer | Sell Option/Award related | 9,919 | $51.53 | $511,126.07 | 57,204 |
| 2 December 2024 | Neil Gregory AlmsteadCTO | Sell Option/Award related | 8,611 | $52.72 | $453,971.92 | 86,202 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.